Symposia 6 - The WHO System for Reporting Soft Tissue Cytopathology: The Rationale, Structure, Categories and Application in
Tracking # 20-1038386
$99999.00
There are no ratings for this course
Learn moreCourse overview
The WHO System for Reporting Soft Tissue Cytopathology has been developed and a book written and published by an expert editorial board of cytopathologists brought together by the WHO publisher IARC in a joint program with the International Academy of Cytology over the last eighteen months. The Reporting System is based on six well defined categories each of which will have a risk of malignancy and recommendation for further diagnostic management. The aim is to standardize the approach to reporting soft tissue cytopathology and improve communication with clinicians and ultimately improve patient care. The key diagnostic cytopathological features have been established by consensus for each lesion or neoplasm, and a discussion of the cytopathological differential diagnosis and the appropriate use of ancillary testing are presented.
Subject areas
This course counts toward the state boards and subject areas below.
Florida Board of Clinical Laboratory Personnel
Clinical Laboratory Director
Clinical Laboratory Supervisor
Clinical Laboratory Technician
Clinical Laboratory Technologist
Public Health Director
Public Health Supervisor
Public Health Technologist
Disclosure statements
The faculty, committee members, Executive Board and staff who are in position to control the content of this activity are required to disclose to the ASC and to learners any financial relationships that have occurred within the last 24 months with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. The ASC has reviewed the disclosures and mitigated all relevant financial relationships.
The following individuals have reported financial relationships:
Michael Berry, SCT(ASCP)MBCM: Stockholder-Hologic
Oscar Lin, MD, PhD: Consultant – Hologic and Jansen
Liron Pantanowitz, MD: Consultant – Hamamatsu, Advisory Board for Ibex
Martha B. Pitman, MD, FIAC: Consultant – Adenocyte, LLC
Donna K. Russell, MEd, CT(ASCP), HT(ASCP): Advisory Board – Hologic Scientific
Christopher J. VandenBussche, MD, PhD: Ad hoc advisory board panel and Consultant – Roche
Paul VanderLaan, MD, PhD: Consultant – Gala Therapeutics